https://www.selleckchem.com/products/rbn-2397.html
Gaining insights that cannot be obtained from health care databases from patients has become an important topic in pharmacovigilance. Our objective was to demonstrate a use case, in which patient-generated data were incorporated in pharmacovigilance, to understand the epidemiology and burden of illness in Japanese patients with systemic lupus erythematosus. We used data on systemic lupus erythematosus, an autoimmune disease that substantially impairs quality of life, from 2 independent data sets. To understand the disease's epidemiolog
Like
Comment
Share
